|
|
|
Price: $5.6500
$0.23 
4.244%
|
| Day's High:
| $5.65
| Week Perf:
| 2.17 %
|
| Day's Low: |
$ 5.40 |
30 Day Perf: |
-8.28 % |
| Volume (M): |
2 |
52 Wk High: |
$ 19.70 |
| Volume (M$): |
$ 13 |
52 Wk Avg: |
$3.81 |
| Open: |
$5.60 |
52 Wk Low: |
$0.25 |
|
|
| Market Capitalization (Millions $) |
4 |
| Shares
Outstanding (Millions) |
1 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
9 |
| Net Income (TTM) (Millions $) |
-4 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Trxade Health Inc
Company Address: 2420 Brunello Trace Lutz 33558 FL
Company Phone Number: 261-0281 Stock Exchange / Ticker: NASDAQ MEDS
| MEDS is expected to report next financial results on March 26, 2024. |
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Bimi International Medical Inc
Bimi International Medical Inc, a renowned medical company, has recently announced its impressive financial results for the fiscal period ending on June 30, 2023. The company generated a substantial revenue of $5.557666 million, which indicates a significant growth in its operations. Moreover, Bimi International Medical Inc also exhibited an improving profit margin, with a net margin of 18.97% and an operating margin of 23.38%.
One notable aspect of their financial statement is the decline in net earnings compared to the corresponding period the previous year. While Bimi International Medical Inc recorded no profits in the previous period, the company experienced a decline in net earnings, which amounted to $1.054 million in the current period. Although this decline might seem alarming at first, the company's overall performance and the growth in revenue indicate that Bimi International Medical Inc is still on a positive trajectory.
|
|
Cosmos Health Inc
Cosmos Health Inc, a company trading on the NASDAQ, has experienced a decline in share prices over the past month, along with a significant drop compared to its 52-week average. However, recent positive developments have been observed, including an increase in COSM shares over the last five trading days. These contrasting trends and the third-quarter financial results indicate some challenges for Cosmos Health Inc, which may have ramifications for the company's future prospects.
1. Share Performance:
- Cosmos Health Inc shares have witnessed a decline of -2.7% over the past 30 days, suggesting a loss of investor confidence.
- COSM shares, on the other hand, have shown growth of 3.85% over the last five trading days, implying a short-term recovery for the company.
|
|
Trees Corporation
Financial News Report: Trees Corporation Reports Improved Earnings and Revenue Growth in Q3 2023
Trees Corporation, a leading Pharmacy Services and Retail Drugstore company, recently announced its financial results for the third quarter of 2023. The company showed significant improvements in earnings per share (EPS) and revenue growth compared to the same period in the previous year.
During the third quarter of 2023 earnings season, Trees Corporation reported a decrease in loss per share of $0.01, compared to a loss of $0.03 per share in the same period a year before. This represents a positive development for the company and demonstrates its efforts to reduce losses. Additionally, the EPS improved from -$0.02 in the preceding financial reporting period.
|
|
Petiq Inc
the third quarter financial results of PetIQ Inc. (NASDAQ: PETQ), a prominent pet medication and wellness company, have been released, investors are provided with substantial evidence of the company's improving financial health. According to the report for the July to September 30, 2023, time-frame, PetIQ Inc. has achieved remarkable improvements in various financial indicators.
First and foremost, the company's earnings turned positive in this period, with a significant increase from a loss of $-1.68 per share to a gain of $0.02 per share compared to the same period last year. This represents a remarkable recovery and reflects the successful implementation of the company's strategic initiatives.
|
|
Cardinal Health Inc
Cardinal Health Inc (CAH) experienced a challenging period in terms of earnings per share (EPS), with a significant decline of -95% to $0.02 per share in the first quarter of 2024. Despite this, the company saw impressive revenue growth of 10.403% to $54.76 billion compared to the same reporting period the previous year.
In the Pharmacy Services and Retail Drugstore sector, Cardinal Health Inc's revenue growth outpaced that of its contemporaries. Two-thirds of businesses in this industry experienced a top-line growth of 9.65% relative to the previous year.
|
| Per Share |
Current |
| Earnings (TTM) |
-3.13 $ |
| Revenues (TTM) |
13.86 $
|
| Cash Flow (TTM) |
- |
| Cash |
1.09 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-3.13 $
|
| Revenues (TTM) |
13.86 $ |
| Cash Flow (TTM) |
- |
| Cash |
1.09 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights
reserved. This site uses cookies to make your browsing experince better. By
using this site, you agree to the Terms of Service and Privacy Policy - UPDATED
(Read about our Privacy Policy)
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
